Ads
related to: biogen alzheimer's drug phase 3- About Treatment
Learn more about the Alzheimer's
treatment option & how it works.
- Alzheimer's Disease Info
Learn about the stages of AD and
diagnostic tests for patients.
- Support & Resources
Patient and care partner support
available on the treatment website.
- For Care Partners
Help support your loved one. View
tips and infusion companion info.
- Getting Started
Find infusion FAQs & tips for
getting started with treatment.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- About Treatment
Search results
Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others
Investor's Business Daily· 2 years agoRoche said its experimental Alzheimer's treatment failed in two final-phase tests, leading Biogen...
Experimental Alzheimer’s drug shows benefits in phase 3 trial, company says
The Today Show via AOL· 2 years agoThe Japanese drugmaker Eisai said Tuesday its experimental drug for Alzheimer’s disease helped slow...
Biogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm
Zacks via Yahoo Finance· 4 months agoBiogen (BIIB) aims to build a leading Alzheimer's disease franchise with the new drug Leqembi. The...
New Alzheimer's drug from Biogen, Eisai gets government approval, but faces long road ahead
Yahoo Finance· 11 months agoA new Alzheimer's drug from Eisai and Biogen (BIIB) is now fully approved by the FDA, opening the...
Biogen stock explodes higher after potential 'mega blockbuster' Alzheimer's drug study
Yahoo Finance· 2 years agoBiogen stock (BIIB) is booming amid as Wall Street speculates about a potential profit boom after a...
Biogen soars 43% after its Alzheimer's drug helps slow down cognitive decline in late-stage study
Business Insider via Yahoo Finance· 2 years agoXinhua/Wang Ying/ Getty Images Biogen soared 43% on Wednesday after the company's Alzheimer's drug...
FDA grants full approval to new Alzheimer's drug meant to slow disease
NBC News via Yahoo News· 11 months agoThe Food and Drug Administration has approved lecanemab, a drug developed by Eisai and Biogen with...
FDA Approves Lecanemab, a New Alzheimer’s Drug
Time via Yahoo News· 1 year agoCredit - Eisai Inc On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages....
Biogen Surges On A Setback For Eli Lilly's Rival Alzheimer's Treatment
Investor's Business Daily· 3 months agoBiogen stock jumped Friday after the Food and Drug Administration delayed its approval decision on...
Biogen (BIIB), Eisai's Alzheimer Drug Likely to Get Full FDA Nod
Zacks via Yahoo Finance· 12 months agoBased on briefing documents issued by the FDA, a full regulatory approval is expected on Biogen...
Ads
related to: biogen alzheimer's drug phase 3